Anna M. Randi, MD,PhD

Professor of Cardiovascular Medicine
Imperial College London

Anna Randi is Professor of Cardiovascular Medicine and Head of Vascular Science at the National Heart and Lung Institute, Imperial College London, UK. Her research interests are in vascular biology and haemostasis. The Randi lab has defined transcriptional and epigenetic mechanisms that control endothelial cell homeostasis and resilience in health and disease and identified of von Willebrand factor as a regulator of angiogenesis. A major effort is directed in using circulating endothelial progenitors from patients’ blood (ECFC), to study mechanisms of disease in patients with von Willebrand disease and in patients with cardiovascular diseases.
Anna Randi is a clinically qualified haematologist, specialized in haemostasis and thrombosis. She trained with Prof. Mannucci at the University of Milan (Italy) and with Dr. Sadler at Washington University, St. Louis (USA); here she was involved in the first characterization of mutations in the von Willebrand factor gene. She moved to the UK to study endothelial biology and vascular diseases, first at GlaxoSmithKline and then at Imperial College London, where she set up her lab in 2003. From April 2022 she is also Visiting Professors at The University of Milan, Italy.
Anna Randi has served on national and international review panels. She has been on the Editorial Board of Blood and is currently Strategic Editor of Bleeding Thrombosis and Vascular Biology (BTVB). From 2013 to 2017 she was Secretary of the European Vascular Biology organisation (EVBO). She is the Scientific Chair (Basic Research) for the London 2022 ISTH meeting; she is a Fellow of the American Heart Association (FAHA). Anna Randi is committed to promoting the careers of young researchers; she believes in providing a supportive and stimulating training and working environment for all, with particular focus on gender equality.

Presentation(s):

• SOA 06.4 - Engineering Microvascular Models

  Sunday, July 10, 2022
  8:00 AM – 9:15 AM

• OC 22.1 - Angiopoietin-2 binds to Von Willebrand Factor within Endothelial Cells and after Release from Weibel Palade Bodies and mediates Von Willebrand Factor dependent angiogenesis

  Sunday, July 10, 2022
  2:45 PM – 3:00 PM

• SOA 13.4 - Vascular Heterogeneity and Functional Crosstalk

  Monday, July 11, 2022
  8:00 AM – 9:15 AM

• PL 04.2 - David Weatherall Plenary Lecture

  Tuesday, July 12, 2022
  9:30 AM – 10:15 AM

• OC 57.3 - Cell-based high throughput screening to identify FDA/EMA approved drugs that inhibit the endothelial pro-thrombotic switch during severe COVID19 infection

  Tuesday, July 12, 2022
  11:15 AM – 11:30 AM

• OC 68.3 - Understanding the role of the renin-angiotensin system in endothelial senescence in chronic obstructive pulmonary disease

  Tuesday, July 12, 2022
  3:15 PM – 3:30 PM

• PB1263 - Evidence for mitochondrial dysfunction in blood-derived endothelial colony forming cells isolated from patients with antiphospholipid syndrome

  Tuesday, July 12, 2022
  6:30 PM – 7:30 PM

• PB1304 - Characterising Endothelial Colony-Forming Cells in The Context Of HIV: People Living with HIV Have Elevated Endothelial Colony-Forming Cell Frequency

  Tuesday, July 12, 2022
  6:30 PM – 7:30 PM

• LB 02.6 - Late Breaking II

  Wednesday, July 13, 2022
  10:15 AM – 11:30 AM

• PL 05.1 - ISTH 2022 Congress Highlights - Basic

  Wednesday, July 13, 2022
  11:45 AM – 12:15 PM